Sarah M Kauss is Director of Thorne Healthtech, Inc.. Currently has a direct ownership of 0 shares of THRN, which is worth approximately $0. The most recent transaction as insider was on Oct 16, 2023, when has been sold 105,874 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Sarah M Kauss Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2023
SELL
Sale (or disposition) back to the issuer
-
105,874 Reduced 100.0%
0 Common Stock
Apr 04 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 22.08%
105,874 Common Stock
Jun 03 2022
BUY
Grant, award, or other acquisition
-
30,874 Added 28.92%
75,874 Common Stock
Apr 04 2022
BUY
Grant, award, or other acquisition
-
30,000 Added 40.0%
45,000 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

LOTZ
CarLotz, Inc. Consumer Cyclical
SMK

Sarah M Kauss

Director
Richmond, VA

Track Institutional and Insider Activities on THRN

Follow Thorne Healthtech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRN shares.

Notify only if

Insider Trading

Get notified when an Thorne Healthtech, Inc. insider buys or sells THRN shares.

Notify only if

News

Receive news related to Thorne Healthtech, Inc.

Track Activities on THRN